# Sildenafil in Heart Failure With Reactive Pulmonary Hypertension

> **NCT02304705** · PHASE4 · TERMINATED · sponsor: **Maya Guglin** · enrollment: 33 (actual)

## Conditions studied

- Heart Failure With Reactive Pulmonary Hypertension

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02304705
- **Lead sponsor:** Maya Guglin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Difficulty meeting enrollment goal
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02304705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02304705, "Sildenafil in Heart Failure With Reactive Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02304705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*